Silence Therapeutics Plc Adr (SLN)

Silence Therapeutics Plc Adr (SLN) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
기간	3개월	3개월	3개월	3개월	3개월
Revenues	100.00%-	0.42	0.03	0.16	0.22
Cost Of Revenue	100.00%-	0.01	0.01	0.06	0.09
Gross Profit	100.00%-	0.41	0.02	0.10	0.14
	0.29%9.15	9.12	-	-	-
Research and Development	0.29%9.15	9.12	-	-	-
Operating Income/Loss	11.90%-13.87	-15.74	-12.46	-26.24	-23.96
Income/Loss From Continuing Operations Before Tax	17.98%-12.27	-14.96	-11.77	-20.96	-27.34
Income Tax Expense/Benefit	0.00	-	-	0.00	0.01
	17.98%-12.27	-14.96	-11.77	-20.96	-27.35
Attributable To Parent	17.98%-12.27	-14.96	-11.77	-20.96	-27.35
Basic Average Shares	0.01%141.71	141.70	0.00	141.70	141.70
Diluted Average Shares	0.01%141.71	141.70	0.00	141.70	141.70
Basic Earnings Per Share	18.18%-0.09	-0.11	-0.09	-0.15	-0.19
Diluted Earnings Per Share	18.18%-0.09	-0.11	-0.09	-0.15	-0.19